Nama's AI scorecard currently rates HCA Healthcare Hold (5.0 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is HCA's P/E ratio?

HCA Healthcare trades at a trailing price-to-earnings ratio of 16.5.

When does HCA report earnings?

HCA Healthcare's next scheduled report is on Jan 26, 2027. Analysts expect EPS of $8.19.

What is the HCA price target?

The median analyst price target from 22 analysts is $488.00, with a range of $380.00 – $550.00.

Is HCA Shariah compliant?

Nama's AAOIFI-style screen reads HCA Healthcare as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Does HCA pay a dividend?

Yes — HCA Healthcare's dividend yield is 0.6%.

Nama Insights

HCA Healthcare (HCA)

Healthcare · Medical Care Facilities · NYSE

S&P 500

HCA Healthcare (HCA) is a Healthcare company in the Medical Care Facilities industry. It has a market capitalization of $103.40B, a trailing price-to-earnings ratio of 16.5 and a free-cash-flow yield of 6.5%. Over the most recent reported fiscal year, revenue grew 7.1% and free cash flow per share grew 49.1%. Nama's AI scorecard rates it Hold, 5.0 out of 10. On 12-month momentum it ranks in the lagging band of its market.

AI scorecard

Hold · 5.0/10

The sections balance. As of Nov 7, 2026.

Momentum

Lagging · -6.8% over 12 months ex. last

Second-worst fifth of its market on the past year's move.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-11.1%

How far the last close sits under the highest price of the past five years.

Market cap	$103.40B
Trailing P/E	16.5
Price / book	—
Price / sales	1.3
FCF yield	6.5%
Dividend yield	0.6%
Gross margin	42.8%
Operating margin	15.3%
Net margin	8.6%
Revenue growth (YoY)	+7.1%
Revenue growth (3-yr annual)	+7.9%
EPS growth (YoY)	+28.6%
FCF/share growth (YoY)	+49.1%
Beta	1.1
Exchange	NYSE
Sector	Healthcare
Industry	Medical Care Facilities

HCA earnings

Next report: Jan 26, 2027 (Q4 2026, EPS estimate $8.19). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Oct 27, 2026	$7.22	$6.63	+8.9%	$19.85B
Q2 2026	Jul 24, 2026	$7.59	$7.50	+1.2%	$20.23B
Q1 2026	Apr 24, 2026	$7.15	$7.13	+0.3%	$19.11B
Q4 2025	Jan 27, 2026	$8.01	$7.48	+7.1%	$19.51B

HCA analyst price target

Median target $488.00 from 22 analysts, ranging $380.00 – $550.00.

Medical Care Facilities peers

Ticker	Company	Market cap	P/E
THC	Tenet Healthcare	$22.55B	12.7
EHC	Encompass Health	$13.50B	22.4
FMS	Fresenius Medical Care	$12.15B	10.2
DVA	DaVita	$12.04B	13.6
UHS	Universal Health Services	$11.52B	8.6
ENSG	Ensign Group	$10.56B	23.8
PACS	PACS Group	$7.87B	20.1
CHE	Chemed	$6.84B	21.2

Explore live HCA data on Nama Insights →

Recent Congressional trades

HCA Healthcare trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Jared Moskowitz	House	Buy	$1,001 - $15,000	Jul 26, 2026
Jared Moskowitz	House	Buy	$1,001 - $15,000	Jul 26, 2026
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Lisa McClain	House	Sell	$1,001 - $15,000	Oct 22, 2025
Lisa McClain	House	Buy	$1,001 - $15,000	Sep 12, 2025
Valerie Hoyle	House	Sell	$1,001 - $15,000	Sep 12, 2025
Valerie Hoyle	House	Buy	$1,001 - $15,000	Sep 12, 2025
Jared Moskowitz	House	Buy	$1,001 - $15,000	Jun 27, 2025
Jared Moskowitz	House	Buy	$1,001 - $15,000	Jun 27, 2025
Julie Johnson	House	Sell	$1,001 - $15,000	May 14, 2025
Rob Bresnahan	House	Sell	$1,001 - $15,000	Mar 27, 2025
Josh Gottheimer	House	Sell	$1,001 - $15,000	Apr 7, 2024

HCA FAQ

Is HCA a buy?: Nama's AI scorecard currently rates HCA Healthcare Hold (5.0 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is HCA's P/E ratio?: HCA Healthcare trades at a trailing price-to-earnings ratio of 16.5.
When does HCA report earnings?: HCA Healthcare's next scheduled report is on Jan 26, 2027. Analysts expect EPS of $8.19.
What is the HCA price target?: The median analyst price target from 22 analysts is $488.00, with a range of $380.00 – $550.00.
Is HCA Shariah compliant?: Nama's AAOIFI-style screen reads HCA Healthcare as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does HCA pay a dividend?: Yes — HCA Healthcare's dividend yield is 0.6%.